TipRanks
Genmab A/S (DE:GE9)
XETRA:GE9
Germany Market
GE9
Genmab A/S
RESEARCH TOOLSreports

Genmab A/S (GE9) Income Statement

15 Followers

Genmab A/S Income Statement

Last quarter (Q2 2026), Genmab A/S's total revenue was kr1.16B, an increase of 24.89% from the same quarter last year. In Q2, Genmab A/S's net income was kr303.00M. See Genmab A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.86Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.48B
Gross Profit
$ 3.54Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.48B
Operating Expenses
$ 2.24Bkr 13.84Bkr 10.93Bkr 8.24Bkr 5.46B
Depreciation and Amortization
$ 73.67Mkr 413.00Mkr 327.00Mkr 362.00Mkr 250.00M
EBITDA
$ 1.37Bkr 9.70Bkr 5.99Bkr 7.33Bkr 3.27B
Operating Income
$ 1.30Bkr 7.00Bkr 5.32Bkr 6.30Bkr 2.95B
Other Income/Expenses
$ -47.73Mkr 2.16Bkr 316.00Mkr 640.00Mkr 965.00M
Pretax Income
$ 1.25Bkr 9.16Bkr 5.64Bkr 6.95Bkr 3.98B
Net Income
$ 999.19Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Per Share Metrics
Basic EPS
$ 16.08kr 122.21kr 66.64kr 83.38kr 46.00
Diluted EPS
$ 15.94kr 121.36kr 66.02kr 82.59kr 45.54
Weighted Average Shares Outstanding
 62.15M 64.63M 65.31M 65.39M 65.40M
Weighted Average Shares Outstanding (Diluted)
 62.69M 64.63M 65.92M 66.01M 66.05M

Genmab A/S Earnings and Revenue History